Vesalius Cardiovascular is a preclinical medical device company in the structural heart space.
Vesalius Cardiovascular has raised $272K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2022.
Vesalius Cardiovascular's investors include VGH and UBC Hospital Foundation.
Vesalius Cardiovascular is headquartered in Vancouver, Canada.
Vesalius Cardiovascular is a preclinical medical device company in the structural heart space.
Vesalius Cardiovascular is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vesalius Cardiovascular — Funding & Investors." VCBacked, January 24, 2022, https://www.vcbacked.co/company/vesalius-cardiovascular. Accessed August 15, 2026.
VCBacked. (2022). Vesalius Cardiovascular — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/vesalius-cardiovascular
{{cite web |title=Vesalius Cardiovascular — Funding & Investors |url=https://www.vcbacked.co/company/vesalius-cardiovascular |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated